ID

30353

Descrizione

https://clinicaltrials.gov/ct2/show/NCT00486954 Study ID: 104578 Clinical Study ID: EGF104578 Study Title: A Randomized, Multicenter, Open-label, Phase III Study of Lapatinib (GW572016) in Combination with weekly Paclitaxel versus weekly Paclitaxel alone in the second line treatment of ErbB2 amplified Advanced Gastric Cancer Patient Level Data: Clinicaltrials.gov Identifier: NCT00486954 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Product Sponsorship Transferred to Novartis Generic Name: lapatinib Trade Name: Tyverb,Tykerb,Tycerb Study Indication: Neoplasms, Gastrointestinal Tract CRF Seiten: 1288-1609

collegamento

https://clinicaltrials.gov/ct2/show/NCT00486954

Keywords

versioni (1)
  1. 29/05/18 29/05/18 - Halim Ugurlu
Titolare del copyright

GlaxoSmithKline (GSK)

Caricato su

29 maggio 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

NCT00486954_Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer

Inglese

Safety Assessment of Interstitial Pneumonitis, Continutation, Status, Concominant Medications

1 moduli  
Safety Assessment of Interstitial Pneumonitis
Descrizione

Safety Assessment of Interstitial Pneumonitis

Alias
UMLS CUI-1
C0206061
Was a chest CT, MRI or x-ray performed as surveillance for interstitial pneumonitis?
Descrizione

If yes, record any findings in teh Adverse Events or Serious Adverse Events from as appropriate

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0206061
UMLS CUI [1,2]
C0920316
UMLS CUI [1,3]
C0733511
UMLS CUI [1,4]
C0011923
Continutation
Descrizione

Continutation

Alias
UMLS CUI-1
C0805733
Will the subject start the next cycle?
Descrizione

Continutation

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0805733
Status
Descrizione

Status

Alias
UMLS CUI-1
C0449438
Were any concominant medications taken by the subject prior to screening and/or during study?
Descrizione

concominant medication

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2347852
Did the subject experience any non-serious adverse events during the study?
Descrizione

non-serious adverse events during the study

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1518404
Did the subject experience any serious adverse events during the study?
Descrizione

Serious adverse events during the study

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1519255
Were any blood products or blood supportive care products used for the subject prior to screening and/or during study?
Descrizione

Blood products or blood supportive care products use

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0456388
UMLS CUI [1,2]
C0457083
Concominant Medications
Descrizione

Concominant Medications

Alias
UMLS CUI-1
C2347852
Drug name
Descrizione

Trade name preferred

Tipo di dati

text

Alias
UMLS CUI [1]
C2360065
Reason for medication
Descrizione

Reason for medication

Tipo di dati

text

Alias
UMLS CUI [1]
C2826696
Start Date
Descrizione

Start Date

Tipo di dati

date

Alias
UMLS CUI [1]
C0808070
Taken prior to study?
Descrizione

Taken prior to study?

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2826667
Ongoing?
Descrizione

Ongoing

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2826666
Ritorna all'inizio della pagina

Similar models

Safety Assessment of Interstitial Pneumonitis, Continutation, Status, Concominant Medications

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Safety Assessment of Interstitial Pneumonitis
C0206061 (UMLS CUI-1)
CT, MRI or x-ray performed as surveillance for interstitial pneumonitis
Item
Was a chest CT, MRI or x-ray performed as surveillance for interstitial pneumonitis?
boolean
C0206061 (UMLS CUI [1,1])
C0920316 (UMLS CUI [1,2])
C0733511 (UMLS CUI [1,3])
C0011923 (UMLS CUI [1,4])
Item Group
Continutation
C0805733 (UMLS CUI-1)
Continutation
Item
Will the subject start the next cycle?
boolean
C0805733 (UMLS CUI [1])
Item Group
Status
C0449438 (UMLS CUI-1)
concominant medication
Item
Were any concominant medications taken by the subject prior to screening and/or during study?
boolean
C2347852 (UMLS CUI [1])
non-serious adverse events during the study
Item
Did the subject experience any non-serious adverse events during the study?
boolean
C1518404 (UMLS CUI [1])
Serious adverse events during the study
Item
Did the subject experience any serious adverse events during the study?
boolean
C1519255 (UMLS CUI [1])
Blood products or blood supportive care products use
Item
Were any blood products or blood supportive care products used for the subject prior to screening and/or during study?
boolean
C0456388 (UMLS CUI [1,1])
C0457083 (UMLS CUI [1,2])
Item Group
Concominant Medications
C2347852 (UMLS CUI-1)
Drug name
Item
Drug name
text
C2360065 (UMLS CUI [1])
Reason for medication
Item
Reason for medication
text
C2826696 (UMLS CUI [1])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1])
Taken prior to study?
Item
Taken prior to study?
boolean
C2826667 (UMLS CUI [1])
Ongoing
Item
Ongoing?
boolean
C2826666 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial